Tenet Healthcare (THC) Tops Q1 EPS by 119c ; Offers Guidance

Tenet Healthcare (NYSE: THC) reported Q1 EPS of $4.36, $1.19 better than the analyst estimate of $3.17. Revenue for the quarter came in at $5.22 billion versus the consensus estimate of $5.14 billion.

GUIDANCE:

Tenet Healthcare sees FY2025 EPS of $11.99-$13.12, versus the consensus of $12.20. Tenet Healthcare sees FY2025 revenue of $20.6-21 billion, versus the consensus of $20.87 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• NRC Health (NRC) Reiterated at Market Outperform by Citizens Ahead of Annual Forum
• Axon Enterprise (AXON) Reiterated at Market Outperform by Citizens After Customer Panel